As reported in the New York Times on May 3rd, the American Urological Association has issued new guidelines concerning the early detection of prostate cancer. The Panel recommends against PSA screening in men under age 40 years; the Panel does not recommend routine screening in men between ages of 40 to 54 years at average risk. For men ages 55 to 69 years the Panel recognizes that the decision to undergo PSA screening involves weighing the benfits of preventing prostat cancer mortality in 1 man for every 1,000 men screened over a decade against known potential harms associated with screening and treatment. For this reason, the Panel strongly recommends shared decision-making for men age 55 to 69 years that are considering PSA screening, and proceed based on a man’s values and preferences. To reduce the harms of screening, a routine screening interval of two years or more may be preferred over annual screening. The Panel does not recommend routine PSA screening in men over age 70 years of age or any man with less than a 10 to 15 year life expectancy. Any questions about the new guidelines should be directed to Dr. Barry Meisenberg or Dr. Robert Hanley. Click here to read full guideline.